Overall, the ERK-induced chemoresistance mediated by ABC transporters is a phenomenon shared by cancers with different histological origin and genetic background and occurs either in the presence of tumor-associated stromal cells or in their absence, leading us to hypothesize that this is a robust and highly conserved mechanism. This evidence concerns the gene MAPK1 and cancer.